Roche Holding

a) The adjusted figures are presented to improve the comparability of current and future consolidated results. They show
the recurring accounting effects of the new and revised International Accounting Standards, which became effective
on 1 January 2000, and of the acquisition of the remaining outstanding shares of Genentech in June 1999 as if they
had already taken place at the beginning of 1999. Furthermore, they exclude special items (impairment charge, gain
from sales of Genentech and...